Beneficial Bacteria to Prevent Malnutrition and Diarrhea in Pakistani Infants
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will determine whether lactobacillus GG (LGG), a beneficial bacterium, when given in yogurt, will reduce growth faltering in babies living in a poor area of Pakistan who are being weaned from breastfeeding.
Study hypothesis: Use of the probiotic bacteria LGG at the time of weaning will lessen the impact of faltering growth in babies living in the slums of Pakistan.
| Condition | Intervention |
|---|---|
|
Malnutrition Diarrhea |
Drug: food supplement: Lactobacillus GG |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Feasibility Study of Probiotics for Growth Faltering in Pakistan |
- Growth, as measured by weight for age and height
- Number of episodes of diarrhea
- duration of episodes of diarrhea
| Estimated Enrollment: | 100 |
| Study Start Date: | March 2006 |
| Estimated Study Completion Date: | January 2008 |
Faltering growth due to malnutrition and recurrent diarrhea is a serious public health concern in developing nations, particularly among infants who are being weaned from breastfeeding. Evidence suggests that the use of the probiotic bacterium LGG reduces the risk of diarrhea, shortens episodes of diarrhea, and enhances the immune system. Babies who are being weaned from breastfeeding will be given LGG-containing yogurt in this study to determine whether LGG will reduce faltering growth caused by diarrhea and malnutrition.
Infant participants will be enrolled at or within 5 weeks of birth and followed throughout the weaning period. During the weaning period, participants will be randomly assigned to either receive LGG-containing yogurt or placebo yogurt everyday for 3 months. All participants will have height and weight measurements taken at study entry and at Month 3 (study completion). The number of diarrhea episodes experienced by participants during the study will be assessed at study completion to determine participants' health.
Eligibility| Ages Eligible for Study: | up to 5 Weeks |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Born and reside in Bilal Colony, Karachi Pakistan during the study
- Parent or guardian willing to provide informed consent
- Parent or guardian willing to permit home visits
- Predominantly breastfed at study start
Exclusion Criteria:
- Malnutrition at time of weaning
- Medical condition that would affect response to LGG
Contacts and Locations| Pakistan | |
| Aga Khan Medical Center | Recruiting |
| Karachi, Pakistan | |
| Contact: Sajid Soofi, MD 92 21 4930051 sajid.soofi@aku.edu | |
| Contact: Zulfiqar A. Bhutta, MD, PhD 92 21 4930051 ext 4724 zulfiqar.bhutta@aku.edu | |
| Sub-Investigator: Zulfiqar A. Bhutta, MD, PhD | |
| Principal Investigator: | Christine A. Wanke, MD | Tufts University |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00118872 History of Changes |
| Other Study ID Numbers: | R21 AT001486-01A2, R21AT001486-01A2, Wanke 01 |
| Study First Received: | July 7, 2005 |
| Last Updated: | December 17, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
|
Growth and Development Pakistan Weaning |
Probiotics Infant Lactobacillus GG |
Additional relevant MeSH terms:
|
Diarrhea Malnutrition Signs and Symptoms, Digestive Signs and Symptoms Nutrition Disorders |
ClinicalTrials.gov processed this record on June 18, 2013